Dacetuzurmab (SGN-40), Lenalidomide, and Weekly Dexamethasone in Relapsed or Refractory Multiple Myeloma: Multiple Responses Observed in a Phase 1b Study

被引：26

作者：

Agura, Edward ^{[1
]}

Niesvizky, Ruben ^{[2
]}

Matous, Jeffrey ^{[3
]}

Munshi, Nikhil ^{[4
]}

Hussein, Mohamad ^{[5
]}

Parameswaran, Ramakrishnan V. ^{[6
]}

Tarantolo, Stefano ^{[7
]}

Whiting, Nancy C. ^{[8
]}

Drachman, Jonathan G. ^{[8
]}

Zonder, Jeffrey A. ^{[9
]}

机构：

[1] Baylor Sammons Canc Ctr, Dallas, TX USA

[2] Weill Cornell Med Coll, New York, NY USA

[3] Rocky Mt Canc Ctr, Denver, CO USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Canc Inst New Jersey, New Brunswick, NJ USA

[6] Avera Canc Inst, Sioux Falls, SD USA

[7] Nebraska Methodist Hosp, Estabrook Canc Ctr, Omaha, NE USA

[8] Seattle Genet Inc, Bothell, WA USA

[9] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

来源：

关键词：

D O I：

10.1182/blood.V114.22.2870.2870

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1120 / 1121

页数：2